Sundrug Co.,Ltd.
TSE:9989.T
3752 (JPY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 751,777 | 690,462 | 648,734 | 634,310 | 617,769 | 588,069 | 564,215 | 528,394 | 503,773 | 445,818 | 447,819 | 407,401 | 386,836 | 360,655 | 284,112 | 232,532 | 218,133 | 197,768 | 177,507 | 153,949 |
Cost of Revenue
| 562,457 | 518,516 | 492,228 | 475,760 | 463,150 | 440,891 | 423,256 | 397,646 | 379,654 | 337,582 | 341,974 | 310,870 | 296,947 | 278,858 | 218,312 | 177,747 | 167,803 | 152,227 | 137,746 | 120,042 |
Gross Profit
| 189,320 | 171,946 | 156,506 | 158,550 | 154,619 | 147,178 | 140,959 | 130,748 | 124,119 | 108,236 | 105,845 | 96,531 | 89,889 | 81,797 | 65,800 | 54,785 | 50,330 | 45,541 | 39,761 | 33,907 |
Gross Profit Ratio
| 0.252 | 0.249 | 0.241 | 0.25 | 0.25 | 0.25 | 0.25 | 0.247 | 0.246 | 0.243 | 0.236 | 0.237 | 0.232 | 0.227 | 0.232 | 0.236 | 0.231 | 0.23 | 0.224 | 0.22 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 318 | 184 | 409 | 179 | 303 | 9 | 9 | 11 |
Selling & Marketing Expenses
| 148,312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 148,323 | 134,495 | 122,454 | 120,879 | 117,996 | 111,671 | 104,620 | 96,507 | 90,868 | 82,168 | 77,500 | 71,582 | 318 | 184 | 409 | 179 | 303 | 9 | 9 | 11 |
Other Expenses
| 635 | 594 | 530 | 660 | 426 | 436 | 582 | 678 | 651 | 453 | 600 | 464 | 456 | 510 | 426 | 175 | 153 | 155 | 171 | 215 |
Operating Expenses
| 148,323 | 134,491 | 122,454 | 121,201 | 118,011 | 111,941 | 104,875 | 96,690 | 91,091 | 82,309 | 77,785 | 71,807 | 39,852 | 37,346 | 29,285 | 23,457 | 21,489 | 32,787 | 27,410 | 22,844 |
Operating Income
| 40,997 | 37,452 | 34,052 | 37,345 | 36,604 | 35,233 | 36,080 | 34,055 | 33,025 | 25,924 | 28,057 | 24,720 | 22,263 | 19,232 | 16,020 | 14,841 | 13,989 | 12,750 | 12,347 | 11,059 |
Operating Income Ratio
| 0.055 | 0.054 | 0.052 | 0.059 | 0.059 | 0.06 | 0.064 | 0.064 | 0.066 | 0.058 | 0.063 | 0.061 | 0.058 | 0.053 | 0.056 | 0.064 | 0.064 | 0.064 | 0.07 | 0.072 |
Total Other Income Expenses Net
| 264 | 259 | 622 | -158 | -1,958 | -164 | 514 | 366 | 250 | 643 | -881 | 304 | -27,581 | -25,584 | -20,210 | -16,472 | -15,449 | 23 | 63 | 188 |
Income Before Tax
| 41,261 | 37,710 | 34,675 | 37,188 | 34,648 | 35,071 | 36,598 | 34,424 | 33,277 | 26,569 | 27,178 | 25,028 | 22,456 | 18,867 | 16,305 | 14,856 | 13,392 | 12,777 | 12,414 | 11,251 |
Income Before Tax Ratio
| 0.055 | 0.055 | 0.053 | 0.059 | 0.056 | 0.06 | 0.065 | 0.065 | 0.066 | 0.06 | 0.061 | 0.061 | 0.058 | 0.052 | 0.057 | 0.064 | 0.061 | 0.065 | 0.07 | 0.073 |
Income Tax Expense
| 12,134 | 12,007 | 10,821 | 11,859 | 10,956 | 11,137 | 11,768 | 11,112 | 11,708 | 10,207 | 11,424 | 10,072 | 9,875 | 7,996 | 6,865 | 5,937 | 5,685 | 5,285 | 5,095 | 4,626 |
Net Income
| 29,126 | 25,703 | 23,853 | 25,329 | 23,692 | 23,933 | 24,829 | 23,312 | 21,569 | 16,362 | 15,754 | 14,955 | 12,580 | 10,871 | 9,440 | 8,918 | 7,706 | 7,492 | 7,319 | 6,625 |
Net Income Ratio
| 0.039 | 0.037 | 0.037 | 0.04 | 0.038 | 0.041 | 0.044 | 0.044 | 0.043 | 0.037 | 0.035 | 0.037 | 0.033 | 0.03 | 0.033 | 0.038 | 0.035 | 0.038 | 0.041 | 0.043 |
EPS
| 249.06 | 219.83 | 204.02 | 216.67 | 202.67 | 204.75 | 212.31 | 197.32 | 178.43 | 133.49 | 124.99 | 118.65 | 99.81 | 86.25 | 74.9 | 70.76 | 61.11 | 59.31 | 114.59 | 103.18 |
EPS Diluted
| 249.06 | 219.81 | 204.01 | 216.63 | 202.66 | 204.75 | 212.31 | 197.31 | 178.43 | 133.48 | 124.99 | 118.65 | 99.81 | 86.25 | 74.9 | 70.76 | 61.11 | 59.31 | 114.59 | 103.18 |
EBITDA
| 56,239 | 50,239 | 44,917 | 46,801 | 45,526 | 44,048 | 44,587 | 41,850 | 40,242 | 32,734 | 34,397 | 30,611 | 55,508 | 49,249 | 40,187 | 34,046 | 31,331 | 14,943 | 14,286 | 12,695 |
EBITDA Ratio
| 0.075 | 0.073 | 0.069 | 0.074 | 0.074 | 0.075 | 0.079 | 0.079 | 0.08 | 0.073 | 0.077 | 0.075 | 0.143 | 0.137 | 0.141 | 0.146 | 0.144 | 0.076 | 0.08 | 0.082 |